MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test
At DNA Labs UAE, we offer the MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test. This test aims to identify mutations in the MYH7 gene, which is responsible for producing a protein called beta-myosin heavy chain. This protein plays a crucial role in the normal functioning of cardiac muscle cells.
Test Components and Price
The MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test is priced at 4400.0 AED. The test can be conducted using blood or extracted DNA, or even a single drop of blood on an FTA card.
Report Delivery
The test results are typically delivered within 3 to 4 weeks after the sample is received.
Method
The MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced genetic testing method allows for the simultaneous analysis of multiple genes, including the MYH7 gene.
Test Type
The MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test falls under the category of Cardiovascular Pneumology Disorders.
Doctor
The test is performed under the guidance of a qualified Cardiologist.
Test Department
The MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test is conducted in the Genetics department of DNA Labs UAE.
Pre Test Information
Prior to undergoing the MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test, it is important for the patient to provide their clinical history. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected by the condition.
Test Details
Familial hypertrophic cardiomyopathy (FHC) is an inherited condition characterized by the thickening of the heart muscle, particularly the left ventricle. This condition is primarily caused by mutations in the MYH7 gene. Symptoms of FHC include shortness of breath, chest pain, dizziness, and fainting. In severe cases, FHC can lead to heart failure or sudden cardiac death.
NGS (Next-Generation Sequencing) is a powerful genetic testing method that can identify mutations in the MYH7 gene and other genes associated with familial hypertrophic cardiomyopathy. By undergoing this test, individuals can determine if they carry any mutations in the MYH7 gene, which may increase their risk of developing the condition.
It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist. These professionals can provide appropriate guidance and support based on the test results.
By offering the MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test, DNA Labs UAE aims to assist individuals in their diagnosis, risk assessment, and family planning.
| Test Name | MYH7 Gene Cardiomyopathy familial hypertrophic type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MYH7 Gene Cardiomyopathy, familial hypertrophic type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH7 Gene Cardiomyopathy, familial hypertrophic type 1 NGS Genetic DNA Test gene MYH7 |
| Test Details |
The MYH7 gene is responsible for providing instructions to make a protein called beta-myosin heavy chain, which is essential for the normal functioning of cardiac muscle cells. Mutations in the MYH7 gene can lead to a condition known as familial hypertrophic cardiomyopathy (FHC), specifically type 1. Familial hypertrophic cardiomyopathy is an inherited condition characterized by the thickening of the heart muscle, particularly the left ventricle. This can result in various symptoms such as shortness of breath, chest pain, dizziness, and fainting. In some cases, FHC can lead to heart failure or sudden cardiac death. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the analysis of multiple genes simultaneously. In the case of familial hypertrophic cardiomyopathy, NGS can be used to identify mutations in the MYH7 gene, as well as other genes associated with the condition. By undergoing an NGS genetic test for familial hypertrophic cardiomyopathy type 1, individuals can determine if they carry any mutations in the MYH7 gene that may predispose them to the condition. This information can be helpful for diagnosis, risk assessment, and family planning. It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist, who can provide appropriate guidance and support based on the results. |
